These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22073284)
21. Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase. von Wantoch Rekowski M; Pyriochou A; Papapetropoulos N; Stössel A; Papapetropoulos A; Giannis A Bioorg Med Chem; 2010 Feb; 18(3):1288-96. PubMed ID: 20036129 [TBL] [Abstract][Full Text] [Related]
22. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433 [TBL] [Abstract][Full Text] [Related]
23. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652 [TBL] [Abstract][Full Text] [Related]
24. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus. De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Yazir Y; Utkan T; Aricioglu F Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):154-60. PubMed ID: 22385503 [TBL] [Abstract][Full Text] [Related]
27. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon. Dhaese I; Vanneste G; Sips P; Buys E; Brouckaert P; Lefebvre RA Eur J Pharmacol; 2008 Jul; 589(1-3):251-9. PubMed ID: 18572161 [TBL] [Abstract][Full Text] [Related]
28. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100 [TBL] [Abstract][Full Text] [Related]
29. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells. Bellamy TC; Garthwaite J Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273 [TBL] [Abstract][Full Text] [Related]
30. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Sobey CG; Faraci FM Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle. Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622 [TBL] [Abstract][Full Text] [Related]
32. cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. Haramis G; Zhou Z; Pyriochou A; Koutsilieris M; Roussos C; Papapetropoulos A Br J Pharmacol; 2008 Nov; 155(6):804-13. PubMed ID: 18695639 [TBL] [Abstract][Full Text] [Related]
33. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519 [TBL] [Abstract][Full Text] [Related]
34. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork. Ellis DZ; Dismuke WM; Chokshi BM Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1808-13. PubMed ID: 19074804 [TBL] [Abstract][Full Text] [Related]
35. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Favaloro JL; Kemp-Harper BK Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101 [TBL] [Abstract][Full Text] [Related]
36. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Duranski MR; Elrod JW; Calvert JW; Bryan NS; Feelisch M; Lefer DJ Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2980-6. PubMed ID: 16877550 [TBL] [Abstract][Full Text] [Related]
37. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G. Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031 [TBL] [Abstract][Full Text] [Related]
38. [Hypotensive effect of oxatriazolo-5-olate derivative in chronic experiments on SHR rats]. Artem'eva MM; Postnikov AB; Akinfieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA Eksp Klin Farmakol; 2009; 72(3):13-5. PubMed ID: 19642586 [TBL] [Abstract][Full Text] [Related]
39. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Chin KY; Qin C; Cao N; Kemp-Harper BK; Woodman OL; Ritchie RH Br J Pharmacol; 2014 Apr; 171(7):1722-34. PubMed ID: 24372173 [TBL] [Abstract][Full Text] [Related]
40. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway. Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]